medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2014, Número 4

<< Anterior

Rev Invest Clin 2014; 66 (4)


Causas de descontrol metabólico en pacientes con diabetes en atención primaria en el Instituto Mexicano del Seguro Social (IMSS)

Wacher NH, Gómez-Díaz RA, Casas-Saavedra LP

Idioma: Español
Referencias bibliográficas: 72
Paginas: 369-378
Archivo PDF: 154.38 Kb.


FRAGMENTO

Hombre de 53 años de edad a quien se le diagnosticó diabetes en forma incidental dos años antes. Se trataba regularmente con su médico familiar. Trabajaba como chofer foráneo, consumía alcohol en forma moderada y fumaba 20 cigarrillos al día. Su padre tuvo diabetes y un infarto del miocardio; su madre, hipertensión arterial. Se sabía hipertenso desde cinco años previos y le practicaron una colecistectomía 11 años previos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Kilpatrick E, Das A, Ørskov C, Berntorp K. Good glycaemic control: an international perspective on bridging the gap between theory and practice in type 2 diabetes. Curr Med Res Op 2008; 24: 2651-61.

  2. Ali M, Bullard K, Saaddine J, Cowie C, Imperatore G, Gregg E. Achievement of Goals in U.S. Diabetes Care, 1999-2010. N Engl J Med 2013; 368: 1613-24.

  3. Pérez-Cuevas R, Doubova S, Suarez-Ortega M, Law M, Pande A, Escobedo J, et al. Evaluating quality of care for patients with type 2 diabetes using electronic health record information in Mexico. BMC Medical Informatics and Decision Making 2012, 12: 50. Disponible en: http://www.biomedcentral.com/ 1472-6947/12/50.

  4. Gutierrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando- Hernandez S, Franco A, Cuevas-Nasu L, et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública (MX), 2012.

  5. Schofield C, Sutherland C. Disordered insulin secretion in the development of insulin resistance and Type 2 diabetes. Diabet Med 2012; 29: 972-9.

  6. UKPDS Group. UK Prospective Diabetes Study 16: overview of six years’ therapy of type 2 diabetes - a progressive disease. Diabetes 1995; 44: 1249-58.

  7. Kellow N, Savige G, Khalil H. Predictors of poor glycaemic control during the initial five years post-diagnosis in rural adults with type 2 diabetes. Aust J Rural Health 2011; 19: 267-74.

  8. Ruelas V, Roybal G, Lu Y, Goldman D, Peters. A Clinical and Behavioral Correlates of Achieving and Maintaining Glycemic Targets in an Underserved Population With Type 2 Diabetes. Diabetes Care 2009; 32: 54-6.

  9. Hernández-Romieu AC, Elnecavé-Olaiz A, Huerta-Uribe N, Reynoso-Noverón N. Análisis de una encuesta poblacional para determinar los factores asociados al control de la diabetes mellitus en México. Sal Pub Mex 2011; 53: 34-9.

  10. Hill J, Galloway J, Goley A, Marrero D, Minners R, Montgomery B, et al. Scientific Statement: Socioecological Determinants of Prediabetes and Type 2 Diabetes. Diabetes Care 2013: 1-10. DOI: 10.2337/dc13-1161.

  11. Padala P, Desouza C, Almeida S, Shivaswamy V, Ariyarathna K, Rouse L, et al. The impact of apathy on glycemic control in diabetes: A cross-sectional study. Diabetes Res Clin Pract 2008; 79: 37-41.

  12. Khattab M, Khader Y, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with Type 2 diabetes. J Diabetes Complications 2010; 24: 84-9.

  13. Rogvi S, Tapager I, Almdal T, Schiøtz M, Willaing I. Patient factors and glycaemic control-associations and explanatory power. Diabet Med 2012; 29; e382-e389.

  14. Cohen H, Shmukler C, Ullman R, Rivera C, Walker E. Measurements of medication adherence in diabetic patients with poorly controlled HbA1c. Diabet Med 2010; 27: 210-6.

  15. Karter A, Parker M, Moffet H, Ahmed A, Schmittdiel J, Selby J. New Prescription Medication Gaps: A Comprehensive Measure of Adherence to New Prescriptions. Health Serv Res 2009; 44: 1640-61.

  16. Currie C, Peyrot M, Morgan C, Poole C, Jenkins-Jones S, Rubin R, et al. The Impact of Treatment Noncompliance on Mortality in People With Type 2 Diabetes. Diabetes Care 2012; 35: 1279-84.

  17. Parada H. Correlates of medication non-adherence among Latinos with type 2 diabetes. Diabetes Educator 2012; 38: 552-61.

  18. Odegard P, Gray S. Barriers to Medication Adherence in Poorly Controlled Diabetes Mellitus. Diabetes Educator 2008; 34: 692-7.

  19. Pan F, Chernew M, Fendrick M. Impact of Fixed-Dose Combination Drugs on Adherence to Prescription Medications. J Gen Intern Med 2008; 23: 611-4.

  20. Thiebaud M, Demand M, Wolf S, Alipuria L, Ye Q, Gutierrez P. Impact of Disease Management on Utilization and Adherence With Drugs and Tests The case of diabetes treatment in the Florida: A Healthy State (FAHS) Program. Diabetes Care 2008; 31: 1717-22.

  21. Lyn E, Ciechanowski P. Working with patients to enhance medication adherence. Clinical Diabetes 2008; 26: 17-9.

  22. Grant R, Cagliero E, Dubey A, Gildesgame C, Chueh H, Barry J, et al. Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med 2004; 21: 150-5.

  23. Lafata J, Dobie E, Divine G, Ulcickas Yood M, McCarthy B. Sustained Hyperglycemia Among Patients With Diabetes What matters when action is needed? Diabetes Care 2009; 32: 1447-52.

  24. Bolen S, Samuels T, Yeh H, Marinopoulos S, McGuire M, Abuid M, Brancati F. Failure to Intensify Antihypertensive Treatment by Primary Care Providers: A Cohort Study in Adults with Diabetes Mellitus and Hypertension. J Gen Intern Med 2008; 23: 543-50.

  25. Bolen S, Bricker E, Samuels T, Yeh H, Marinopoulos S, McGuire M, et al. Factors Associated With Intensification of Oral Diabetes Medications in Primary Care Provider-Patient Dyads: A Cohort Study. Diabetes Care 2009; 32: 25-31.

  26. McEwen L, Bilik D, Johnson S, Halter J, Karter A, Mangione C, et al. Predictors and Impact of Intensification of Antihyperglycemic Therapy in Type 2 Diabetes Translating Research into Action for Diabetes (TRIAD). Diabetes Care 2009; 32: 971-6.

  27. Rodondi N, Peng T, Karter A, Bauer D, Vittinghoff E, Tang S, et al. Therapy Modifications in Response to Poorly Controlled Hypertension, Dyslipidemia, and Diabetes Mellitus. Ann Intern Med 2006; 144: 475-84.

  28. Ho P, Magid D, Shetterly S, Olson K, Peterson P, Masoudi F, et al. Importance of Therapy Intensification and Medication Nonadherence for Blood Pressure Control in Patients With Coronary Disease. Arch Intern Med 2008; 168: 271-6.

  29. Ratanawongsa N, Crosson J, Schillinger D, Karter A, Saha Ch, Marrero D. Getting Under the Skin of Clinical Inertia in Insulin Initiation : The Translating Research Into Action for Diabetes (TRIAD) Insulin Starts Project. Diabetes Educator 2012; 38: 94-100.

  30. Shah B, Hux J, Laupacis A, Zinman B, van Walraven C. Clinical Inertia in Response to Inadequate Glycemic Control Do specialists differ from primary care physicians? Diabetes Care 2005; 28: 600-06.

  31. Schmittdiel J, Uratsu C, Karter A, Heisler M, Subramanian U, Mangione C, et al. Why Don’t Diabetes Patients Achieve Recommended Risk Factor Targets? Poor Adherence versus Lack of Treatment Intensification. J Gen Intern Med 2008; 23: 588-94.

  32. O’Connor P. Commentary-Improving Diabetes Care by Combating Clinical Inertia. Health Serv Res 2005; 40 (6, Part I): 1854-61.

  33. Petitti D, Contreras R, Ziel F, Dudl J, Domurat E, Hyatt J. Evaluation of the Effect of Performance Monitoring and Feedback on Care Process, Utilization, and Outcome. Diabetes Care 2000; 23: 192-6.

  34. Ziemer D, Doyle J, Barnes C, Branch W, Cook C, El-Kebbi I, et al. An Intervention to Overcome Clinical Inertia and Improve Diabetes Mellitus Control in a Primary Care Setting Improving Primary Care of African Americans With Diabetes (IPCAAD). Arch Intern Med 2006; 166: 507-13.

  35. Anderson G, Chu E. Expanding Priorities-Confronting Chronic Disease in Countries with Low Income. N Engl J Med 2007; 356: 209-11.

  36. Montori V, Dinneen S, Gorman C, Zimmerman S, Rjizza R, Bjornstein S, et al. for the Translation Project Investigator Group The Impact of Planed Care and Diabetes Electronic Management System on Community-Based Diabetes Care: The Mayo Health System Diabetes Translation Project. Diabetes Care 2002; 25: 1952-7.

  37. Shojania K, Ranji S, McDonald K, Grimshaw J, Sundaram V, Rushakoff R, et al. Effects of Quality Improvement Strategies for Type 2 Diabetes on Glycemic Control A Meta-Regression Analysis. JAMA 2006; 296: 427-40.

  38. Nicolucci A, Rossi M, Arcangeli A, Cimino A, de Bigontina G, Fava G, et al. On behalf of AMD-Annals Study Group Four-year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics: the AMD-Annals initiative. Diabet Med 2010; 27: 1041-8.

  39. Bright T, Wong A, Dhurjati R, Bristow E, Bastian L, Coeytaux R, et al. Effect of Clinical Decision-Support Systems A Systematic Review. Ann Intern Med 2012; 157: 29-43.

  40. Seitz P, Rosemann T, Gensichen J, Huber C. Interventions in primary care to improve cardiovascular risk factors and glycated haemoglobin (HbA1c) levels in patients with diabetes: a systematic review. Diabetes, Obes Metab 2011; 13: 479-89.

  41. Fokkens A, Wiegersma P, Beltman F, Reijneveld S. Structured primary care for type 2 diabetes has positive effects on clinical outcomes. J Eval Clin Pract 2011; 17: 1083-8.

  42. Golfracht M, Levin D, Peled O, Poraz I, Stern E, Bramil JL, et al. Twelve-year follow-up of a population-based primary care diabetes program in Israel. Int J Qual Health Care 2011; 23: 674-81.

  43. Centor R. A Hospitalist Inpatient System Does Not Improve Patient Care Outcomes. Arch Intern Med 2008; 168: 1257-8.

  44. Pérez-Cuevas R, Reyes-Morales H, Flores-Hernández S, Wacher-Rodarte N. Efecto de una Guía de Práctica Clínica para el manejo de la Diabetes tipo 2. Rev Med Inst Mex Seguro Soc 2007; 45: 353-60.

  45. Welch G, Garb J, Zagarins S, Lendel I, Gabbay R. Nurse diabetes case management interventions and blood glucose control: Results of a meta-analysis. Diab Res Clin Pract 2010; 88: 1-6.

  46. Siminerio L, Drab S, Gabbay R, Gold K, McLaughlin S, Piatt G, et al. Diabetes Educators: Implementing the Chronic Care Model. Diabetes Educator 2008; 34; 451-6.

  47. Fisher E, Brownson C, O’Toole M, Anwuri V. Ongoing Follow- up and Support for Chronic Disease Management in the Robert Wood Johnson Foundation Diabetes Initiative. Diabetes Educator 2007; 33: 2018-78.

  48. Von Korff M, Gruman J, Schaefer J, Curry S, Wagner E. Collaborative Management of Chronic Illness. Ann Intern Med 1997; 127: 1097-102.

  49. Wisse W, Rookhuizen M, de Kruif M, van Rossum J, Jordans I, ten Cate H, et al. Prescription of physical activity is not sufficient to change sedentary behavior and improve glycemic control in type 2 diabetes patients. Diabetes Res and Clin Pract 2010; 88: e10-e13.

  50. Peyrot M, Rubin R, Siminero L. On Behalf of the International DAWN Advisory Panel Physician and Nurse Use of Psychosocial Strategies in Diabetes Care Results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabetes Care 2006; 29: 1256-62.

  51. Barnard K, Peyrot M, Holt R. Psychosocial support for people with diabetes: past, present and future. Diabet Med 2012; 29; 1358-60.

  52. Abildsnes E, Walseth L, Flottorp S, Stensland P. Power and powerlessness: GPs’ narratives about lifestyle counseling. Br J Gen Pract 2012;62(596): e160-e166. DOI: 10.3399/ bjgp12X630043.

  53. Critchley C, Hardie E, Moore S. Examining the Psychological Pathways to Behavior Change in a Group-Based Lifestyle Program to Prevent Type 2 Diabetes. Diabetes Care 2012; 35: 699-705.

  54. Fiscella K, Epstein R. So Much to Do, So Little Time Care for the Socially Disadvantaged and the 15-Minute Visit. Arch Intern Med 2008; 168: 1843-52.

  55. Nutting P, Dickinson W, Dickinson L, Nelson C, King D, Crabtree B, et al. Use of Chronic Care Model Elements Is Associated With Higher-Quality Care for Diabetes. Ann Fam Med 2007; 5: 14-20. DOI: 10.1370/afm.610.

  56. Steinsbekk A, Rygg L, Lisulo M, Rise M, Fretheim. A Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis. BMC Health Serv Res 2012; 12: 213.

  57. Iglehart J. No Place Like Home-Testing a New Model of Care Delivery. N Engl J Med 2008; 359: 1200-2.

  58. Salinas-Martínez A, Garza-Sagástegui MG, Cobos-Cruz R, Núñez-Rocha G, Garza-Elizondo M, Peralta-Chávez D. Diabetes y consulta médica grupal en atención primaria. ¿Vale la pena el cambio? Rev Med Chile 2009; 137: 1323-32.

  59. Fan L, Sidani S. Effectiveness of Diabetes Self-management Education Intervention Elements: A Meta-analysis. Can J Diabetes 2009; 33: 18-26.

  60. Berry L, Rock B, Smith Houskamp B, Brueggeman J, Tucker L. Care Coordination for Patients With Complex Health Profiles in Inpatient and Outpatient Settings. Mayo Clin Proc 2013; 88: 184-94.

  61. Sperl-Hillen J, Beaton S, Fernandes O, Von Worley A, Vazquez- Benitez G, Parker E, et al. Comparative Effectiveness of Patient Education Methods for Type 2 Diabetes A Randomized Controlled Trial. Arch Intern Med 2011; 171: 2001-10.

  62. Zeh P, Sandhu H, Cannaby A, Sturt J. The impact of culturally competent diabetes care interventions for improving diabetesrelated outcomes in ethnic minority groups: a systematic review. Diabet Med 2012; 29: 1237-52.

  63. Gebregziabher M, Egede L, Lynch C, Echols C, Zhao Y. Effect of Trajectories of Glycemic Control on Mortality in Type 2 Diabetes: A Semiparametric Joint Modeling Approach. Am J Epidemiol 2010; 171: 1090-8.

  64. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.

  65. Holman R, Paul S, Bethel A, Matthews D, Neil A. 10-Year Follow- up of Intensive Glucose Control in Type 2 Diabetes. N Engl J Med 2008; 359: 1577-89.

  66. Gæde P, Valentine J, Palmer J, Tucker DM, Lammert M, Parving HH, et al. Cost-effectiveness of intensified versus convencional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study. Diabetes Care 2008; 31: 1510-05.

  67. Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, et al. American Diabetes Association; American College of Cardiology Foundation. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care 2008; 31: 811-22.

  68. Pi-Sunyer X, Blackburn G, Bracanti F, Bray G, Bright R, Clark J, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one year results of the look AHEAD trial. Diabetes Care 2007; 30: 1374-83.

  69. Tabrizi J, Wilson A, O’Rourke P, Coyne E. Patient Perspectives on Consistency of Medical Care With Recommended Care in Type 2 Diabetes. Diabetes Care 2007; 30: 2855-6.

  70. Fu A, Qiu Y, Davies M, Radican L, Engel S. Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy. Diabetes Obes Metab 2011; 13: 765-9.

  71. Nakar S, Yitzhaki G, Rosenberg G, Vinker S. Transition to insulin in Type 2 diabetes: family physicians’ misconception of patients’ fears contributes to existing barriers. J Diabetes Complications 2007; 21: 220-6.

  72. Shani M, Taylor T, Vinker S, Lustman A, Erez R, Elhayany A, et al. Characteristics of Diabetics with Poor Glycemic Control Who Achieve Good Control. J Am Board Fam Med 2008; 21: 490-6.




2020     |     www.medigraphic.com